Janux Therapeutics (NASDAQ: JANX) is a clinical-stage biotech developing a new class of cancer immunotherapies known as tumor-activated bispecifics. These therapies are designed to redirect…
May 06, 2025
Janux Therapeutics (NASDAQ: JANX) is a clinical-stage biotech developing a new class of cancer immunotherapies known as tumor-activated bispecifics. These therapies are designed to redirect…